Market Value635,216,000
Total Holdings45
File Date2018-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IOVA / Iovance Biotherapeutics, Inc. Call
GWP / GW Pharmaceuticals plc
TSRO / TESARO, Inc. Call
EXAS / Exact Sciences Corporation
71426VAK4 / Pernix Therapeutics Holdings, Inc. Convertible Debt 4.25%
IVTY / Invuity, Inc.
GKOS / Glaukos Corporation
HZNP / Horizon Therapeutics Plc Call
NUVA / Nuvasive Inc
US00163U1060 / AMAG Pharmaceuticals, Inc.
ESPR / Esperion Therapeutics, Inc.
MTD / Mettler-Toledo International Inc.
SRRA / Sierra Oncology Inc
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
PRTK / Paratek Pharmaceuticals Inc.
GBT / Global Blood Therapeutics Inc.
/ Oxford Immunotec Global PLC
ODT / Odonate Therapeutics Inc
PACB / Pacific Biosciences of California, Inc.
XERS / Xeris Biopharma Holdings, Inc.
TNDM / Tandem Diabetes Care, Inc.
VCYT / Veracyte, Inc.
ANGO / AngioDynamics, Inc.
NVLN / NOVELION THERAPEUTICS INC.
NTUS / Natus Medical Inc
PCRX / Pacira BioSciences, Inc.
MDWD / MediWound Ltd.
CI / The Cigna Group
IART / Integra LifeSciences Holdings Corporation
PGNX / Progenics Pharmaceuticals, Inc. Call
REPH / Societal CDMO Inc
VCEL / Vericel Corporation
LJPC / La Jolla Pharmaceutical Co.
ZGNX / Zogenix Inc
ZGNX / Zogenix Inc Put
ANAB / AnaptysBio, Inc.
NVTA / Invitae Corporation
CFRX / ContraFect Corp
MRK / Merck & Co., Inc.
ADMS / Adamas Pharmaceuticals Inc
AVDL / Avadel Pharmaceuticals plc
CORI / Corium International, Inc.
KALA / KALA BIO, Inc.
XRAY / DENTSPLY SIRONA Inc.
IOVA / Iovance Biotherapeutics, Inc.
PETX / Aratana Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.
ATRS / Antares Pharma Inc
SBBP / Strongbridge Biopharma plc
SLGL / Sol-Gel Technologies Ltd.
LIVN / LivaNova PLC
US92220P1057 / Varian Medical Systems, Inc.
SSKN / STRATA Skin Sciences, Inc.
ENDP / Endo International plc Call
CDTX / Cidara Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Call
TLGT / Teligent Inc
ENDP / Endo International plc
TVTX / Travere Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
HRTX / Heron Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc. Call
MRTX / Mirati Therapeutics, Inc.
ADMA / ADMA Biologics, Inc.
BDSI / Biodelivery Sciences International
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
CPRX / Catalyst Pharmaceuticals, Inc.
SCYX / SCYNEXIS, Inc.
QTNT / Quotient Ltd